Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| https://www.w3.org/2000/01/rdf-schema#label |
A-381
|
| gptkbp:ingredients |
C20 H25 N3 O2 S
|
| gptkbp:is_used_for |
treatment of certain medical conditions
|
| gptkbp:previous_name |
(2 S)-N-[(1 S)-1-(4-methylphenyl)ethyl]-2-(4-methylphenyl)-2-(methylsulfonyl)acetamide
|
| gptkbp:project |
clinical trials
|
| gptkbp:related_to |
antidepressant drugs
|
| gptkbp:targets |
gptkb:drug
|
| gptkbp:type_of |
123456-78-9
|
| gptkbp:weight |
357.49 g/mol
|
| gptkbp:year_created |
gptkb:2000
|
| gptkbp:bfsParent |
gptkb:AP-4_Motorway
|
| gptkbp:bfsLayer |
6
|